- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)
Total 71 results
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Genentech, Inc.Approved for marketing
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
Hoffmann-La RocheActive, not recruiting
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
Ferring PharmaceuticalsCompletedPrimary Amenorrhea With Hypogonadotropic HypogonadismUnited States, Canada
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
NewAmsterdam PharmaCompletedHealthy Volunteer StudyUnited States
-
AgendiaUniversity of South Florida; University of Miami; University of Oklahoma; Ohio... and other collaboratorsCompletedBreast CancerUnited States
-
MedSIRHoffmann-La RocheNot yet recruiting
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
ANRS, Emerging Infectious DiseasesGilead Sciences; Ministry of Health, Thailand; Assistance Publique - Hôpitaux... and other collaboratorsRecruiting
-
Bristol-Myers SquibbCompleted
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Ulrik LassenGlaxoSmithKline; Pfizer; Roche Pharma AGRecruitingNeoplasms | Cancer | Tumors | NeoplasiaDenmark
-
Janssen Research & Development, LLCCompleted
-
Raymond T. Chung, MDMerck Sharp & Dohme LLCWithdrawnHepatitis C | Cardiac Transplant DisorderUnited States
-
Timothy Morgan, MDBristol-Myers Squibb; National Cancer Institute (NCI); VA Long Beach Healthcare...Completed
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
ANRS, Emerging Infectious DiseasesNot yet recruiting
-
AstraZenecaCompletedPharmacokinetics | Effect of FoodUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Bristol-Myers SquibbCompletedHepatitis C Virus InfectionJapan
-
Janssen Research & Development, LLCCompleted
-
Emory UniversityCenters for Disease Control and PreventionCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
GlaxoSmithKlineCompleted
-
Janssen Research & Development, LLCCompleted
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
TakedaCompletedDiabetes MellitusChina, Taiwan, Korea, Republic of, Malaysia
-
Boehringer IngelheimCompleted
-
Astellas Pharma Europe B.V.CompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaBelgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
-
Esperion Therapeutics, Inc.Completed
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
Research in Real-Life LtdChiesi Farmaceutici S.p.A.Completed
-
Seoul National University Bundang HospitalRoche Pharma AG; Korean Cancer Study GroupRecruitingSolid Tumor | Metastatic Cancer | Advanced Solid TumorKorea, Republic of
-
Philip GrantWithdrawnHIV/AIDS | Osteopenia | HIV-1-infectionUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyWithdrawnMixed Dyslipidemia | Primary Hypercholesterolemia
-
American Society of Clinical OncologyBristol-Myers Squibb; Eli Lilly and Company; Bayer; Merck Sharp & Dohme LLC; Pfizer; AstraZene... and other collaboratorsRecruitingLymphoma, Non-Hodgkin | Multiple Myeloma | Advanced Solid TumorsUnited States